361380-77-0 Usage
Uses
Used in Organic Synthesis:
3,5-DIMETHYL-1H-PYRROLE-2,4-DICARBOXYLIC ACID 4-TERT-BUTYL ESTER 2-ETHYL ESTER is used as a building block in organic synthesis for constructing more complex molecules. Its unique structure and functional groups contribute to the formation of a variety of organic compounds.
Used in Pharmaceutical Research:
In Pharmaceutical Research, 3,5-DIMETHYL-1H-PYRROLE-2,4-DICARBOXYLIC ACID 4-TERT-BUTYL ESTER 2-ETHYL ESTER is utilized as a key intermediate in the development of new drugs. Its potential applications in drug discovery are attributed to its ability to interact with biological systems, offering a promising avenue for the creation of novel therapeutic agents.
Used in Materials Science:
3,5-DIMETHYL-1H-PYRROLE-2,4-DICARBOXYLIC ACID 4-TERT-BUTYL ESTER 2-ETHYL ESTER may also find applications in materials science, where its distinctive structure and functionality can be employed to develop new materials with specific properties for various applications.
Used in Chemical Engineering:
In Chemical Engineering, 3,5-DIMETHYL-1H-PYRROLE-2,4-DICARBOXYLIC ACID 4-TERT-BUTYL ESTER 2-ETHYL ESTER could be utilized for various purposes, including the development of new chemical processes or the enhancement of existing ones, capitalizing on its unique structural and functional attributes.
Check Digit Verification of cas no
The CAS Registry Mumber 361380-77-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,6,1,3,8 and 0 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 361380-77:
(8*3)+(7*6)+(6*1)+(5*3)+(4*8)+(3*0)+(2*7)+(1*7)=140
140 % 10 = 0
So 361380-77-0 is a valid CAS Registry Number.
InChI:InChI=1/C14H21NO4/c1-7-18-13(17)11-8(2)10(9(3)15-11)12(16)19-14(4,5)6/h15H,7H2,1-6H3
361380-77-0Relevant academic research and scientific papers
NOVEL FUSED PYRIDAZINE DERIVATIVES
-
, (2011/05/06)
The present invention relates to novel fused pyridazine compounds, their pharmaceutically acceptable salts, and their isomers, stereoisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses pharmaceutically acceptable compositions of said compounds and process for preparing novel compounds. The invention further relates to the use of the above-mentioned compounds for the preparation of medicament for use as pharmaceuticals.
